Skip to main content
Industry News
US pledges $1.2B for 300M doses of AstraZeneca COVID-19 vaccine

The US has pledged up to $1.2 billion from the Biomedical Advanced Research and Development Authority for 300 million doses of the experimental COVID-19 vaccine AZD1222 being developed jointly by AstraZeneca and the University of Oxford. The target availability date of the first doses could be as early as October, according to an HHS statement.

Full Story: